Login
 Forum
 
 
Personal data sheet
 Print preview
personal data approved: 2015. III. 24.
Personal data
Hajnalka Andrikovics
name Hajnalka Andrikovics
year of birth 1972
name of institution
doctoral school
ELTE Doctoral School of Biology (Announcer of research topic)
SE Doctoral School of Clinical Medicine (Supervisor)
the share of work in the different doctoral schools. ELTE Doctoral School of Biology 20%
SE Doctoral School of Clinical Medicine 80%
Contact details
E-mail address andrikovics.hajnalkaovsz.hu
phone number +36 1 372-4449
Academic title
scientific degree, title Ph.D.
year degree was obtained 2004
discipline to which degree belongs theoretical medicine
institution granting the degree Semmelweis University
Employment
2001 - Országos Vérellátó Szolgálat (research institute, not university)
other (not specified) (laborvezető)
Thesis topic supervisor
number of doctoral students supervised until now 4
number of students who fulfilled course requirements 1
students who obtained their degrees:
(50%) Magdalena Renata Koszarska PhD 2015  DSB-ELTE
(50%) Nóra Meggyesi PhD 2012  DSMM-SE

completed course requirement, without degree or degree granting in process:
Katalin Balassa (PhD) 2015/08  DSCM-SE
Tünde Krähling (PhD) 2016/08  DSCM-SE
present PhD students:
Katalin Piroska Kiss (PhD) (2018/08)  DSCM-SE
  Thesis topic proposals
Research
research area Investigation of the interaction between several inherited and acquired molecular genetic genetic lesions in the pathomechanism of oncohaematological in order to set up personalized treatment protoco
research field in which current research is conducted clinical medicine
Publications
2015

Varga G, Mikala G, Andrikovics H, Koszarska M, Balassa K, Adam E, Kozma A, Tordai A, Masszi T: NFKB1 -94ins/delATTG polymorphism is a novel prognostic marker in first line-treated multiple myeloma., BRITISH JOURNAL OF HAEMATOLOGY In press: p. In press.
type of document: Journal paper/Article
impact factor: 4.959**
language: English
DOI 
2014

Andrikovics H, Krahling T, Balassa K, Halm G, Bors A, Koszarska M, Batai A, Dolgos J, Csomor J, Egyed M, Sipos A, Remenyi P, Tordai A, Masszi T: Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations, HAEMATOLOGICA 99: (7)
type of document: Journal paper/Article
number of independent citations: 20
language: English
DOI 
2014

Rajnai H, Heyning FH, Koens L, Sebestyén A, Andrikovics H, Hogendoorn PCW, Matolcsy A, Szepesi Á: The density of CD8+ T-cell infiltration and expression of BCL2 predicts outcome of primary diffuse large B-cell lymphoma of bone, VIRCHOWS ARCHIV 464: (2)
type of document: Journal paper/Article
number of independent citations: 4
language: English
DOI 
2014

Koszarska M, Kucsma N, Kiss K, Varady G, Gera M, Antalffy G, Andrikovics H, Tordai A, Studzian M, Strapagiel D, Pulaski L, Tani Y, Sarkadi B, Szakacs G: Screening the Expression of ABCB6 in Erythrocytes Reveals an Unexpectedly High Frequency of Lan Mutations in Healthy Individuals., PLOS ONE 9: (10) p. e111590.
type of document: Journal paper/Article
language: English
URL 
2012

Kasza I, Varady G, Andrikovics H, Koszarska M, Tordai A, Scheffer GL, Nemeth A, Szakacs G, Sarkadi B: Expression Levels of the ABCG2 Multidrug Transporter in Human Erythrocytes Correspond to Pharmacologically Relevant Genetic Variations., PLOS ONE 7: (11) 8 p. Paper e48423.
type of document: Journal paper/Article
number of independent citations: 4
language: English
DOI 
2012

Meggyesi N, Kalmár L, Fekete S, Masszi T, Tordai A, Andrikovics H: Characterization of ABL exon 7 deletion by molecular genetic and bioinformatic methods reveals no association with imatinib resistance in chronic myeloid leukemia, MEDICAL ONCOLOGY 29: (3)
type of document: Journal paper/Article
language: English
DOI 
2009

Andrikovics H, Meggyesi N, Szilvasi A, Tamaska J, Halm G, Lueff S, Nahajevszky S, Egyed M, Varkonyi J, Mikala G, Sipos A, Kalasz L, Masszi T, Tordai A: HFE C282Y Mutation as a Genetic Modifier Influencing Disease Susceptibility for Chronic Myeloproliferative Disease, CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 18: (3)
type of document: Journal paper/Article
number of independent citations: 5
language: English
DOI 
2009

Kasza I, Hegyi Z, Szabo K, Andrikovics H, Német K, Váradi A, Sarkadi B, Homolya L: Model system for the analysis of cell surface expression of human ABCA1., BMC CELL BIOLOGY 10: p. 93.
type of document: Journal paper/Article
impact factor: 2.654
number of independent citations: 8
language: English
DOI 
2008

Erdélyi DJ, Kamory E, Csokay B, Andrikovics H, Tordai A, Kiss C, Félné-Semsei A, Janszky I, Zalka A, Fekete G, Falus A, Kovacs GT, Szalai C: Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy., PHARMACOGENOMICS JOURNAL 8: (5)
type of document: Journal paper/Article
number of independent citations: 21
language: English
DOI 
2007

Ribiczey P, Tordai A, Andrikovics H, Filoteo AG, Penniston JT, Enouf J, Enyedi A, Papp B, Kovacs T: Isoform-specific up-regulation of plasma membrane Ca(2+)ATPase expression during colon and gastric cancer cell differentiation, CELL CALCIUM 42: (6)
type of document: Journal paper/Article
number of independent citations: 16
language: English
DOI 
Number of independent citations to these publications:78 
Scientometric data
list of publications and citations
number of scientific publications that meet accreditation criteria:
49
number of scientific publications:
130
monographs and professional books:
0
monographs/books in which chapters/sections were contributed:
2 
scientific publications published abroad that meet the accreditation criteria:
37
publications not in Hungarian, published in Hungary, meeting the accreditation criteria:
0
number of independent citations to scientific publications and creative works:
591

 
All rights reserved © 2007, Hungarian Doctoral Council. Doctoral Council registration number at commissioner for data protection: 02003/0001. Program version: 1.2318 ( 2016. XI. 26. )